Influenza and COVID-19 Vaccine Concerns and Uptake Among Patients Cared for in a Safety-Net Health System

J Prim Care Community Health. 2022 Jan-Dec:13:21501319221136361. doi: 10.1177/21501319221136361.

Abstract

Objectives: To examine Influenza and COVID-19 vaccine concerns and uptake among adult patients in a Southern safety-net health system.

Methods: Trained research assistants conducted a structured telephone interview from April to October 2021. Of 118 participants, mean age was 57.7 years, 63.6% were female, 55.1% were Black, 42.4% white, and 54.2% reported rural residence.

Results: Among participants, 44.9% had received the influenza vaccine during the 2020 to 2021 season, and 66.1% had received the COVID-19 vaccine. Participants who received the influenza vaccine were more likely to report getting a COVID-19 vaccine compared to those who reported not getting a flu vaccine (81.1% vs 53.8%, P = .002). Black adults were significantly less likely than white adults (29.2% vs 46.0%, P = .048) and bordering on significance, males less likely than females (27.9% vs 41.3%, P = .054) to have reported receiving both vaccines. Of note, 25.4% of participants did not get either vaccine. The most common reasons for not getting the influenza vaccine were not being concerned about getting the flu (13.8%) and belief the vaccine gave them the flu (12.3%). The primary reasons for not getting a COVID-19 vaccine were concern about vaccine safety (22.5%), concern about side effects (20.0%), and belief they were not going to get sick (20.0%).

Conclusions: These findings could help direct regional vaccine messaging and clinical communication to improve vaccine uptake among underserved populations.

Keywords: COVID-19 and Influenza concerns; COVID-19 and influenza vaccine uptake.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • COVID-19 / prevention & control
  • COVID-19 Vaccines* / adverse effects
  • Female
  • Humans
  • Influenza Vaccines* / adverse effects
  • Influenza, Human / prevention & control
  • Male
  • Middle Aged
  • Safety-net Providers*
  • Vaccination* / psychology
  • Vaccination* / statistics & numerical data

Substances

  • COVID-19 Vaccines
  • Influenza Vaccines